A detailed history of Long View Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Long View Wealth Management holds 435 shares of LLY stock, worth $392,678. This represents 0.15% of its overall portfolio holdings.

Number of Shares
435
Previous 440 1.14%
Holding current value
$392,678
Previous $343 Million 15.07%
% of portfolio
0.15%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $3,624 - $4,545
-5 Reduced 1.14%
435 $394 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $12,436 - $16,637
-21 Reduced 4.56%
440 $343 Million
Q4 2023

Jan 10, 2024

BUY
$525.19 - $619.13 $242,112 - $285,418
461 New
461 $289 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Long View Wealth Management Portfolio

Follow Long View Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long View Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Long View Wealth Management with notifications on news.